Clinical Trial: Node-sparing short-course neoadjuvant radiotherapy followed by chemotherapy and immunotherapy in locally advanced mid-low rectal cancer: Efficacy and safety (China)

Posted On: 2026-09-23

China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Node-sparing short-course neoadjuvant radiotherapy followed by chemotherapy and immunotherapy in locally advanced mid-low rectal cancer: Efficacy and safety'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133169

Registration Time: 2026/09/22

Type: Interventional study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=291003

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Node-sparing short-course neoadjuvant radiotherapy followed by chemotherapy and immunotherapy in locally advanced mid-low rectal cancer: Efficacy and safety (China)